- In September 2024, Helaina completed a Series B funding round, raising USD 45 million, led by Avidity Partners. In addition, this funding boosts Helaina’s total equity funding to USD 83 million and will support the launch of their human lactoferrin product, branded as effera, aimed at the women’s health, active nutrition, and healthy aging markets
- In August 2024, De Novo Foodlabs, known for producing animal-free lactoferrin through precision fermentation, secured USD 1.5 million in seed funding, led by Joyful VC in California. In addition, this investment will help accelerate the commercialization of their product, NanoFerrin, enabling greater production scale and market reach within the food technology industry
- In February 2023, Morinaga Milk Industry Co., Ltd. acquired shares in Le May Production, a company specializing in the import and export of infant and toddler milk. In addition, this move aims to bolster the nutritional infrastructure in Asia
- In August 2022, Morinaga Milk Industry Co., Ltd. received FDA GRAS (Generally Recognized as Safe) approval for its Probiotic Bifidobacterium infantis M-63, which is now approved for use in infant formula and general foods
- In May 2022, Glanbia PLC acquired Sterling Technology, a U.S.-based producer of dairy bioactive solutions derived from bovine colostrum. In addition, this acquisition is part of Glanbia's strategy to expand its brand presence in the market
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Apolactoferrin and Hololactoferrin), Source (Rice Flour, Human Milk, and Animal Milk), Function (Iron Absorption, Anti-Inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, and Antioxidant), Application (Food and Beverages, Infant Formula, Sports and Functional Food, Animal Feed, Pharmaceuticals, Personal Care Products, and Others), Type (Freeze Dried Lactoferrin and Spray Dried Lactoferrin), Product Form (Powder, Capsule, and Others), Distribution Channel (Supermarket/Hypermarket, Online, Drugstore, Nutrition and Health Food Store, and Others) – Industry Trends and Forecast to 2032
.
The Global Lactoferrin Market size was valued at USD 293.00 USD Million in 2024.
The Global Lactoferrin Market is projected to grow at a CAGR of 7.5% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
